James Falconer
Internal Medicine · Thomasville, GANPI 1295704641
Payments from drug & device makers
Across 277 payments — averaging $2342.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$646K
- Novo Nordisk$379
- AstraZeneca$354
- LEO Pharma Inc.$291
- GSK$267
- Amgen$266
- plus $2K from 32 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 70 | $645,539 |
| Novo Nordisk | 23 | $379 |
| AstraZeneca | 24 | $354 |
| LEO Pharma Inc. | 12 | $291 |
| GSK | 14 | $267 |
| Amgen | 17 | $266 |
| Boehringer Ingelheim | 14 | $234 |
| Lilly USA, LLC | 17 | $176 |
| Astellas Pharma US Inc | 10 | $171 |
| Johnson & Johnson | 12 | $158 |
| AbbVie | 7 | $125 |
| Merck | 7 | $89 |
| Regeneron Healthcare Solutions, Inc. | 4 | $77 |
| Seqirus USA Inc | 4 | $75 |
| Sunovion Pharmaceuticals Inc. | 4 | $71 |
| Jazz Pharmaceuticals Inc. | 4 | $64 |
| Sanofi Pasteur Inc. | 4 | $53 |
| Bayer | 2 | $38 |
| Novartis | 2 | $36 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Grifols USA, LLC | 2 | $32 |
| Mallinckrodt Hospital Products Inc. | 2 | $32 |
| Insmed, Inc. | 2 | $28 |
| Incyte Corporation | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Almatica Pharma LLC | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 3 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Organogenesis Inc. | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $16 |
| Abbott | 1 | $14 |
| Inari Medical, Inc. | 1 | $13 |
| Actelion Pharmaceuticals US, Inc. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
| Valeritas, Inc. | 1 | $11 |
| Inogen, Inc. | 1 | $8 |
How this compares
$648,848 in reported general payments places this provider in the 95th percentile of 3,311 internal medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Thomasville
- William CooperThomasville$1M
- Paul BradleySavannah$76.4M
- Kimball JohnsonAtlanta$51.1M
- Bram WieskopfWoodstock$21.9M
- Dwight BlakeUnion City$13.3M
- Charlotte Grayson-MathisFayetteville$9.6M
- Christopher RecknorGainesville$9.2M
- James HarperJohns Creek$9.2M
- Robert Springer IiiAtlanta$5.3M
- Thomas MoriaritySavannah$4.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.